Post-effective amendment to a registration statement that is not immediately effective upon filing

Share-Based Compensation (Tables)

v3.22.2
Share-Based Compensation (Tables)
12 Months Ended
Dec. 31, 2021
Share-Based Payment Arrangement [Abstract]  
Schedule of stock option activity
     

Outstanding
share options

 

Weighted-
average
exercise
price ($)

 

Weighted
average
remaining
contractual
life (years)

 

Aggregate
intrinsic
value ($ in
thousands)

   

Options:

   

 

           

Outstanding as of December 31, 2018

 

3,213,497

 

 

0.447

 

5.839

 

244,579

Granted

 

847,443

 

 

1.295

       

Forfeited

 

(368,675

)

 

0.599

       

Exercised

 

(136,461

)

 

0.000

 

2.875

   

Outstanding as of December 31, 2019

 

3,555,804

 

 

0.652

 

5.024

 

109,779

Granted

 

932,835

 

 

1.199

       

Forfeited

 

(494,450

)

 

1.042

       

Exercised

 

(226,155

)

 

0.132

 

2.072

   

Outstanding as of December 31, 2020

 

3,768,034

 

 

0.767

 

4.626

 

119,146

Granted

 

1,966,916

 

 

7.250

       

Forfeited

 

(117,863

)

 

0.972

       

Exercised

 

(155,750

)

 

0.602

 

2.684

   

Outstanding as of December 31, 2021

 

5,461,337

 

 

3.102

 

5.363

 

16,713,971

Exercisable as of December 31, 2021

 

2,854,952

 

 

0.671

 

3.329

   

Options available for future grants

 

36,981

 

           
Schedule of RSUs activity
   

Number of
RSUs

Outstanding as of January 1, 2021

 

Granted

 

1,968,974

Vested

 

Forfeited

 

Outstanding as of December 31, 2021

 

1,968,974

Schedule of compensation to employees
     

Year ended December 31,

   

2021

 

2020

 

2019

Expected term, in years

 

4.61 – 6.11

 

4.61

 

4.61

Expected volatility

 

42% – 46%

 

42.02% – 42.64%

 

42.81% – 50.15%

Risk-free interest rate

 

0.49% – 1.28%

 

0.24% – 1.42%

 

1.51% – 2.20%

Expected dividend yield

 

0%

 

0%

 

0%

Schedule of share-based compensation expense
     

Year ended December 31,

   

2021

 

2020

 

2019

Research and development

 

$

1,518

 

$

320

 

$

303

Sales and marketing

 

 

217

 

 

65

 

 

72

General and administrative

 

 

419

 

 

46

 

 

36

Cost of revenues

 

 

57

 

 

8

 

 

Total share-based compensation expense

 

$

2,211

 

$

439

 

$

411